BioSpace News Archive

an international consortium of researchers and physicians is the first to distinguish three risk groups in multiple myeloma (ultra-low, intermediate and high-risk patients) and show a favorable and distinct treatment strategy for the low and high-risk patients in an interim data analysis.

As Britain continues to move forward with its plans to leave the European Union, a new report indicates that the so-called “Brexit” will have a negative impact on healthcare in the United Kingdom.

Orexo AB today announces that the US Court of Appeals for the Federal Circuit has denied Actavis Elizabeth LLC’s (Actavis) combined petition for panel rehearing and rehearing en banc in the case regarding Orexo’s Zubsolv US patent 8,940,330.

LimaCorporate is pleased to announce the launch of the SMR TT Hybrid Glenoid, the latest addition to the SMR Shoulder System.

Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother’s gut are passed on to the baby and stimulate the baby’s immune responses.

The successful synthesis of large-area single-crystal heterostructure of 2D materials

Transaction would expand Ecolab’s offerings for life sciences and healthcare environments

As Mo Bros across Canada prepare to farewell their moustaches on November 30, the Movember Foundation is urging them to shave-down to a ‘Half-Mast Mo’ in one final fundraising act for men’s health.

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares.

- Uptravi now funded for the majority of Canadians with pulmonary arterial hypertension, but other treatments remain out of reach -